Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Janos Bacsanyi"'
Publikováno v:
AIDS patient care and STDs. 14(8)
The association between pharmacologic doses of corticosteroids and the development of aseptic bone necrosis has been well documented. Recent reports have described the corticosteroid activity of megestrol acetate. A retrospective review of adverse ev
Autor:
Janos Bacsanyi, Marianne Mann, Matthew Leinung, Elizabeth Koller, Saul Malozowski, Anthony J. Murgo
Publikováno v:
Archives of internal medicine. 157(15)
Sporadic single case reports linking glucocorticoidlike activity to megestrol acetate have been reported in the literature. These findings have important implications for patient care. Adverse drug experience reports to the US Food and Drug Administr
Autor:
Diane K. Wysowski, Janos Bacsanyi
Publikováno v:
The New England journal of medicine. 335(4)
To the Editor: From September 1993, the month in which the marketing of cisapride (Propulsid, Janssen Pharmaceutica, Titusville, N.J.) began, to April 1996, the Food and Drug Administration's MedWa...
Autor:
Janos Bacsanyi, Diane K. Wysowksi
Publikováno v:
JAMA: The Journal of the American Medical Association. 276:952
To the Editor. —Ticlopidine hydrochloride (Ticlid, Roche Laboratories, Nutley, NJ) is an antiplatelet drug that has been marketed in the United States since October 1991. Based on reports since then, the labeling of ticlopidine has been changed. Ti